Skip to content
10-K

Annual Report

IRIS BIOTECHNOLOGIES INC

0001554795-14-000249

← back to feed
Filed
Mar 31, 2014 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2013 · Mar 28, 2014 14.79M sh
Capex FY 2013 · Dec 31, 2013 $228.37K
Operating Cash Flow FY 2013 · Dec 31, 2013 −$3.59M
Operating Cash Flow FY 2013 · Dec 31, 2012 −$272.69K
Eps Basic FY 2013 · Dec 31, 2013 −$0.04
Eps Basic FY 2013 · Dec 31, 2012 −$0.05
Sga Expense FY 2013 · Dec 31, 2013 $5.55M
Sga Expense FY 2013 · Dec 31, 2012 $440.15K
Rd Expense FY 2013 · Dec 31, 2013 $2.26M
Rd Expense FY 2013 · Dec 31, 2012 $130.19K
Net Income FY 2013 · Dec 31, 2013 −$9.68M
Net Income FY 2013 · Dec 31, 2012 −$585.95K
Current Liabilities FY 2013 · Dec 31, 2012 $96.8K
Total Liabilities FY 2013 · Dec 31, 2012 $143.8K
Current Assets FY 2013 · Dec 31, 2012 $15.76K
Total Assets FY 2013 · Dec 31, 2012 $24.72K
Operating Income FY 2013 · Dec 31, 2012 $2.69M
Cash And Equivalents FY 2013 · Dec 31, 2011 $43.73K
Stockholders Equity FY 2013 · Dec 31, 2011 $31.88K